Porcine Xenograft Versus Second Intention Healing
NCT03931746 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14
Last updated 2023-03-20
Summary
The purpose of this research study is to test whether it is better to allow patients with post- operative wounds on the legs to heal on their own without a covering or to use a porcine xenograft (skin graft that is made from pig cells) to cover the wound during healing. It is currently not known which option is better in terms of the appearance, complication rate or the impact on the patient's quality of life during the healing process. In this location, it is common receive either treatment.
Conditions
- Wound Healing and Scar Quality Following Mohs Surgery and Excisional Dermatologic Surgery
Interventions
- DEVICE
-
Porcine xenograft
The EZ-DERM™ porcine xenograft is a biosynthetic dressing made from porcine collagen containing aldehyde crosslinking. It has been most commonly applied to the management of 2nd degree burns, both partial-thickness and full-thickness defects. This dressing can be used for two healing purposes, either for primary healing or as an intermediate in the preparation for a skin graft
Sponsors & Collaborators
-
Northwell Health
lead OTHER
Principal Investigators
-
Victoria Sharon, MD · Northwell Health
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-06-11
- Primary Completion
- 2021-02-01
- Completion
- 2021-02-01
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Safety and Efficacy Study of APIC-PRP in Non-healing Diabetic Foot Ulcers
NCT02209662 ·Status: UNKNOWN ·Phase: NA
-
Effect of Platelet Concentrate in Treatment of Diabetic Ulcers
NCT00215735 ·Status: TERMINATED ·Phase: NA
-
A Case Series Evaluating a Collagen Wound Dressing to Treat Wounds
NCT03909503 ·Status: WITHDRAWN ·Phase: NA
-
A Pilot Study of the Provant Therapy System in Subjects With Diabetic Foot Ulcers
NCT00761176 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers
NCT01853384 ·Status: TERMINATED ·Phase: PHASE3
-
Pivotal Trial of Dermagraft(R) to Treat Diabetic Foot Ulcers
NCT01181453 ·Status: COMPLETED ·Phase: PHASE3
-
A Study, Performed in Subjects With Post Traumatic-post Surgical ,Venus Insufficiency and Diabetic Hard to Heal/Chronic Wounds, to Evaluate the Safety and Efficacy of PolyHeal-2 Versus PolyHeal in Once Daily Regimen
NCT01679678 ·Status: TERMINATED ·Phase: PHASE2
-
Study of SANTYL® vs Hydrogel (SoloSite®) for Pressure Ulcers
NCT02718625 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluating Intact Fish Skin Graft and Standard of Care Versus Standard of Care Alone in Nonhealing Venous Leg Ulcers
NCT06693570 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.
NCT06437028 ·Status: RECRUITING ·Phase: NA
-
Clinical Effectiveness of Topical Autologous Platelet Gel for the Treatment of Venous Ulcers
NCT00273234 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot Ulcers
NCT06852976 ·Status: RECRUITING ·Phase: PHASE2
-
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
NCT02071979 ·Status: TERMINATED ·Phase: NA
-
Dermagraft(R) for the Treatment of Patients With Diabetic Foot Ulcers
NCT01181440 ·Status: COMPLETED ·Phase: PHASE3
-
Allogenic Dermis Versus Standard Care in the Management of Diabetic Foot Ulcers
NCT02331147 ·Status: COMPLETED ·Phase: NA
-
Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
NCT07086443 ·Status: RECRUITING ·Phase: PHASE4
-
Study to Evaluate the PICO 14 Negative Pressure Wound Therapy System in the Management of Acute and Chronic Wounds
NCT05234632 ·Status: TERMINATED
-
IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers
NCT06616844 ·Status: RECRUITING ·Phase: NA
-
Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
NCT07089602 ·Status: RECRUITING ·Phase: PHASE4
-
Study of Amniotic Membrane Graft in the Management of Diabetic Foot Ulcers
NCT02399826 ·Status: UNKNOWN ·Phase: NA
-
Negative Pressure Wound Therapy for the Treatment of Chronic Pressure Wounds
NCT00691821 ·Status: TERMINATED ·Phase: PHASE4
-
Effectiveness Study of Santyl Ointment to Treat Pressure Ulcers
NCT01208220 ·Status: TERMINATED ·Phase: NA
-
A Randomized Comparison of AmnioClear™ Human Allograft Amniotic Membrane vs. Moist Wound Dressing in the Treatment of Diabetic Wounds
NCT02120755 ·Status: WITHDRAWN ·Phase: PHASE4
-
Bioactive Split Thickness Skin Allograft Versus Standard of Care in the Treatment of Diabetic Foot Ulcers
NCT04040426 ·Status: COMPLETED ·Phase: NA
-
Randomized Controlled Clinical Investigation Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System in the Healing of Diabetic Foot Ulcers
NCT05519501 ·Status: COMPLETED ·Phase: NA